mkdir -p /home/daytona/workspace/anki-neetpg && cat > /home/daytona/workspace/anki-neetpg/cell_injury_adaptation.txt << 'ANKI_EOF' Cell Injury and Cell Adaptation (Pathology - NEET PG 2027) <b>CAUSES OF CELL INJURY</b><br><br>1. <b>Hypoxia and Ischemia</b>: Most common cause - oxygen deficiency (hypoxia) and reduced blood supply (ischemia). Ischemia also reduces nutrients. Common causes: arterial blockage, lung disease, anemia. Ischemia is more damaging than pure hypoxia.<br><br>2. <b>Toxins</b>: Environmental chemicals (air pollutants, insecticides, carbon monoxide, asbestos, cigarette smoke, ethanol, drugs). Two mechanisms: (a) Direct-acting - mercury binds sulfhydryl groups of membrane proteins, diphtheria toxin inhibits protein synthesis, anthrax toxin degrades MAP kinases. (b) Latent toxins - converted to reactive metabolites by cytochrome P-450 in smooth ER of liver, e.g., CCl4 converted to CCl3 free radical causing lipid peroxidation, acetaminophen (leading cause of acute liver failure in USA) toxic at high doses via P-450 pathway.<br><br>3. <b>Infectious Agents</b>: Viruses, bacteria, fungi, parasites - injure cells by liberating toxins and eliciting harmful immune responses.<br><br>4. <b>Immunologic Reactions</b>: Autoimmune reactions, allergic reactions, excessive chronic immune responses to microbes - all elicit inflammatory reactions causing cell and tissue damage.<br><br>5. <b>Genetic Abnormalities</b>: Chromosomal abnormalities or mutations - e.g., Down syndrome (chromosomal), sickle cell anemia (single amino acid substitution in hemoglobin). May cause decreased or increased protein function, accumulation of damaged DNA or misfolded proteins triggering cell death. Central role in cancer.<br><br>6. <b>Nutritional Imbalances</b>: Protein-calorie insufficiency (common globally), specific vitamin deficiencies; also excessive dietary intake causing obesity, underlying type 2 diabetes and many diseases.<br><br>7. <b>Physical Agents</b>: Mechanical trauma, extreme temperatures (burns, frostbite), radiation, electric shock, atmospheric pressure changes.<br><br>8. <b>Aging</b>: Progressive cellular aging leading to reduced functional capacity and death.<br><br><b>FACTORS AFFECTING CELL INJURY (CELLULAR RESPONSE)</b><br><br><b>Key Mechanisms of Cell Injury</b><br><br>1. <b>Mitochondrial Dysfunction and Damage</b>: Decreased ATP production leads to failure of Na-K-ATPase pump causing cell swelling, loss of microvilli, blebs in plasma membrane. Anaerobic glycolysis increases lactic acid causing pH fall. Ribosomes detach from ER reducing protein synthesis. Irreversible injury: dense amorphous deposits in mitochondria (flocculent densities), lysosomal rupture, plasma membrane damage. Mitochondrial permeability transition pore (MPTP) opens causing cytochrome c release triggering apoptosis.<br><br>2. <b>Oxidative Stress - Reactive Oxygen Species (ROS)</b>: ROS generated by: incomplete reduction of O2 in mitochondria, metabolism of chemicals by cytochrome P-450, leukocyte burst activity, iron or copper catalysis (Fenton reaction). Removed by: superoxide dismutase (SOD converts O2 to H2O2), glutathione peroxidase, catalase. ROS cause injury by: lipid peroxidation of membranes, oxidation and cross-linking of proteins, DNA strand breaks. Ischemia-reperfusion injury: increased ROS on reoxygenation, influx of calcium, complement activation, leukocyte-mediated injury.<br><br>3. <b>Membrane Damage</b>: Decreased phospholipid synthesis, increased phospholipid breakdown (phospholipases activated by Ca2+), cytoskeletal damage, ROS-mediated lipid peroxidation. Lysosomal membrane damage releases enzymes causing autolysis.<br><br>4. <b>Disturbance in Calcium Homeostasis</b>: Normal intracellular Ca2+ is very low (0.1 micromol). Ischemia and toxins cause increased cytosolic Ca2+ activating phospholipases (membrane damage), proteases (cytoskeletal and structural protein breakdown), ATPases (decreased ATP), endonucleases (DNA and chromatin damage), triggering apoptosis pathways.<br><br>5. <b>Endoplasmic Reticulum Stress</b>: Accumulation of misfolded proteins triggers unfolded protein response (UPR). If ER stress is prolonged, triggers apoptosis via caspase-12 pathway. Seen in neurodegenerative diseases (Alzheimer's, Parkinson's), diabetes, atherosclerosis.<br><br>6. <b>DNA Damage</b>: Radiation, ROS, chemotherapeutic drugs cause DNA strand breaks. If repair fails, p53 activation induces apoptosis.<br><br><b>Reversible vs Irreversible Injury</b><br><br><b>Reversible injury</b>: Cell swelling (most common earliest change), fatty change, clumping of nuclear chromatin, ribosome detachment, plasma membrane blebbing, swelling of ER and mitochondria.<br><br><b>Irreversible injury (points of no return)</b>: Inability to restore mitochondrial function, profound disturbances in membrane function. Morphologic hallmarks: (a) nuclear changes - pyknosis (nuclear condensation), karyorrhexis (fragmentation), karyolysis (dissolution); (b) flocculent densities in mitochondria; (c) lysosomal rupture.<br><br><b>Factors determining cell vulnerability</b>: Type of cell (neurons most vulnerable to hypoxia - die in 3-5 minutes, myocardium in 20-30 minutes, skeletal muscle hours), metabolic state of cell, nutritional status, duration and severity of injury, blood supply, innate defense mechanisms.<br><br><b>CELLULAR ADAPTATIONS TO STRESS</b><br><br>Adaptations = reversible changes in number, size, phenotype, metabolic activity, or functions of cells in response to environmental changes. May be physiologic (normal hormonal stimulation) or pathologic (in response to stress). If stress exceeds adaptive capacity, cell injury occurs.<br><br><b>1. HYPERTROPHY</b><br><br><b>Definition</b>: Increase in cell SIZE (not number), resulting in increased size of organ.<br><br><b>Occurs in</b>: Non-dividing cells (permanent cells) - cardiomyocytes, skeletal muscle cells, neurons.<br><br><b>Mechanism</b>: Increased production of cellular structural components. Triggered by mechanical signals (increased workload), trophic signals (growth factors: IGF-1, TGF-beta), and vasoactive agents (angiotensin II, alpha-adrenergic agonists). Signaling pathways: PI3K-Akt pathway (physiologic - exercise-induced), GPCR-mediated pathway via MAPK (pathologic - pressure overload). Results in activation of transcription factors (GATA4, NFAT, MEF2) and increased synthesis of contractile proteins (actin, myosin), re-expression of fetal genes (ANF - atrial natriuretic factor, BNP - brain natriuretic peptide).<br><br><b>Physiologic examples</b>: Skeletal muscle enlargement with exercise (bodybuilding), uterine enlargement in pregnancy (combined hypertrophy and hyperplasia), cardiac hypertrophy in athletes.<br><br><b>Pathologic examples</b>: Left ventricular hypertrophy (LVH) in systemic hypertension (pressure overload) or aortic stenosis, right ventricular hypertrophy in pulmonary hypertension, cardiac hypertrophy in aortic regurgitation (volume overload).<br><br><b>Key Exam Points</b>: LVH is eccentric (dilated chamber, volume overload) vs concentric (thick wall, pressure overload). Hypertrophied heart can undergo decompensation leading to dilated cardiomyopathy. ANF and BNP are markers of cardiac hypertrophy and heart failure.<br><br><b>2. HYPERPLASIA</b><br><br><b>Definition</b>: Increase in cell NUMBER due to increased proliferation of stem cells or mature cells, resulting in increased size of organ.<br><br><b>Occurs in</b>: Dividing (labile and stable) cells - epithelial cells, hepatocytes, fibroblasts. Cannot occur in permanent cells (neurons, cardiomyocytes).<br><br><b>Mechanism</b>: Growth factors bind receptors activating signaling cascades (RAS-MAPK, PI3K-Akt, JAK-STAT) leading to increased transcription factors promoting cell cycle entry and DNA synthesis. Stem cells are activated to divide and differentiate.<br><br><b>Physiologic examples</b>: Hormonal hyperplasia - breast glandular epithelium in puberty and pregnancy, endometrial proliferation in menstrual cycle, erythroid hyperplasia at high altitude. Compensatory hyperplasia - liver regeneration after partial hepatectomy, bone marrow hyperplasia after blood loss.<br><br><b>Pathologic examples</b>: Benign prostatic hyperplasia (BPH) - due to excess DHT (dihydrotestosterone) stimulation, endometrial hyperplasia due to excess estrogen (risk of endometrial carcinoma), psoriasis (epidermal hyperplasia), Grave's disease (thyroid follicular cell hyperplasia). Hyperplasia due to viral infections: HPV causing squamous cell hyperplasia (condyloma acuminata - cauliflower lesion of external genitalia).<br><br><b>Key Exam Points</b>: Hyperplasia is under normal regulatory control - cells respond to growth signals and can revert when signals stop. Hyperplasia can progress to dysplasia and neoplasia if genetic mutations accumulate (e.g., endometrial hyperplasia to carcinoma). Hyperplasia vs hypertrophy - heart and skeletal muscle undergo hypertrophy because mature cells cannot divide; liver and kidney undergo hyperplasia because cells can divide.<br><br><b>3. ATROPHY</b><br><br><b>Definition</b>: Decrease in cell SIZE due to loss of cell substance (protein degradation exceeds synthesis), resulting in reduced organ size. May be followed by cell death.<br><br><b>Occurs in</b>: Any dividing or non-dividing cell.<br><br><b>Mechanism</b>: Two main degradation pathways: (a) Ubiquitin-proteasome pathway - activated by nutrient deprivation and disuse; proteins tagged with ubiquitin are degraded in proteasomes. Atrophy-specific E3 ubiquitin ligases: MuRF1 and MAFbx/atrogin-1 (muscle-specific). Triggered by increased glucocorticoids and decreased IGF-1/insulin signaling. (b) Autophagy - cell degrades its own organelles via lysosomes. Creates autophagic vacuoles (seen in atrophic cells as lipofuscin-containing vacuoles). Atrophic cells show increased lipofuscin (brown pigment, wear-and-tear pigment).<br><br><b>Causes and Examples</b>:<br>- Disuse (immobilization) atrophy: limb in cast, prolonged bed rest - skeletal muscle atrophy<br>- Denervation atrophy: lower motor neuron (LMN) lesion - skeletal muscle atrophy (flaccid paralysis)<br>- Loss of endocrine stimulation: post-menopausal uterine and vaginal atrophy, adrenal atrophy after prolonged corticosteroid therapy<br>- Inadequate nutrition (marasmus): protein-calorie malnutrition, skeletal muscle and fat atrophy; brain spared<br>- Pressure atrophy: growing tumor compressing adjacent tissue (e.g., renal atrophy by hydronephrosis)<br>- Aging (senile atrophy): brain atrophy in Alzheimer's, testicular atrophy with aging<br>- Vascular insufficiency: ischemia leading to tissue atrophy<br><br><b>Key Exam Points</b>: Atrophy = reduced size but cells remain viable. Distinguish from aplasia (no cells formed) and hypoplasia (fewer cells). Brown atrophy of heart: lipofuscin accumulation (seen with aging, cachexia). Cushing syndrome or prolonged steroid use causes muscle atrophy and skin atrophy.<br><br><b>4. METAPLASIA</b><br><br><b>Definition</b>: Reversible change in which one adult cell type (epithelial or mesenchymal) is replaced by another adult cell type, better able to withstand adverse environment. NOT a change in individual cells but reprogramming of stem cells.<br><br><b>Mechanism</b>: Reprogramming of tissue stem cells due to cytokines, growth factors, and ECM components in the tissue environment. Key signal: retinoic acid and growth factors alter gene expression patterns. Transcription factors (e.g., RUNX, CDX2, NKX) drive differentiation of stem cells along new lineage.<br><br><b>Types and Examples</b>:<br><br><b>Epithelial Metaplasia</b>:<br>- Squamous metaplasia of respiratory epithelium: chronic irritation from cigarette smoke causes replacement of columnar ciliated epithelium by stratified squamous epithelium in bronchi. Loss of cilia and mucus secretion impairs defense. Risk of squamous cell carcinoma of lung.<br>- Squamous metaplasia of endocervix: normal columnar epithelium of endocervix is replaced by squamous epithelium at transformation zone. Physiologic in adults. HPV infects transformation zone cells - risk of cervical squamous cell carcinoma.<br>- Squamous metaplasia of bladder: chronic inflammation from schistosomiasis (Schistosoma haematobium) causes squamous metaplasia of transitional (urothelial) epithelium. Risk of squamous cell carcinoma of bladder.<br>- Barrett's esophagus: chronic GERD (acid reflux) causes replacement of normal stratified squamous epithelium of lower esophagus by intestinal columnar epithelium with goblet cells (intestinal metaplasia). Risk of esophageal adenocarcinoma (most important premalignant lesion of esophagus).<br>- Intestinal metaplasia of stomach: chronic H. pylori gastritis causes replacement of gastric mucosa by intestinal-type epithelium. Risk of gastric adenocarcinoma.<br>- Apocrine metaplasia in breast: fibrocystic change - ductal epithelium replaced by apocrine-type cells.<br><br><b>Mesenchymal (Connective Tissue) Metaplasia</b>:<br>- Osseous metaplasia: formation of bone in soft tissues. Examples: myositis ossificans (bone in muscle after trauma), bone in aortic atherosclerotic plaques, lamellar bone in old scars.<br>- Cartilaginous metaplasia: rare, in fibrous tissue near joints after injury.<br><br><b>Key Exam Points</b>: Metaplasia is protective adaptation but at expense of normal function. It is reversible if stimulus removed (e.g., smoking cessation can reverse bronchial squamous metaplasia). Metaplasia does NOT directly become cancer but creates fertile ground for carcinogenesis if genetic mutations accumulate. Mnemonic for squamous metaplasia sites: BBEC - Bladder (Schistosoma), Bronchus (smoking), Endocervix (chronic irritation), (Barrett's esophagus = intestinal metaplasia). Vitamin A deficiency causes squamous metaplasia of respiratory and urinary tract epithelium. Vitamin A excess corrects squamous metaplasia.<br><br><b>SUMMARY TABLE - ADAPTATIONS</b><br><br>Hypertrophy: SIZE up, number same, non-dividing cells, e.g., cardiac LVH, skeletal muscle with exercise. Hyperplasia: NUMBER up, size same, dividing cells, e.g., BPH, endometrial hyperplasia, liver regeneration. Atrophy: SIZE down (cell substance loss), any cell type, e.g., disuse, denervation, senile. Metaplasia: cell TYPE change (adult to adult), stem cell reprogramming, e.g., Barrett's esophagus, bronchial squamous metaplasia, bladder squamous metaplasia. ANKI_EOF echo "File created. Checking line count:" wc -l /home/daytona/workspace/anki-neetpg/cell_injury_adaptation.txt